Up-regulation of PLK1 in some of the breast cancer subtypes may inhibit tumor development by interfering with cytokinesis and mitosis [92,93] as well as one of the NIMA kinases NEK9, which is associated with tumor growth prevention, when upregulated [94]. This evidence concerns the gene NEK9 and breast carcinoma.